NYAS brought together leaders in biomedicine, green energy, urban development, and innovation policy to discuss how science and technology could transform Mexico's capital. A new eBriefing documents the highlights.
Dec 8, 2008• 8:30 AM - 5:30 PM Organ Toxicity in Drug Development: Biomarkers and Novel Approaches Speakers: Ellen Evans, Schering-Plough Corporation; Liang Guo, Hoffmann-La Roche Inc.; Sally Hargus, Food and Drug Administration/CDER; Diwakar Jain, Drexel University College of Medicine; Thomas T. Kawabata, Pfizer Global Research and Development; William B. Mattes, The Critical Path Institute; John R. Senior, Food and Drug Administration/CDER; James Stoltz, Boehringer-Ingelheim Pharmaceuticals, Inc.; Paul Watkins, University of North Carolina, Chapel Hill; James Weaver, Food and Drug Administration/CDER; Jinghai James Xu, Merck & Co. Inc. Register Now
Keynote Speaker: Sam Pitroda, Alvin Toffler, Jerry Hultin, Hugo Santana, Rajendra Pachauri, Harry Kroto, Robert Richardson, Rajeev Sethi, Robert Engle, Sherwood Rowland, Russell Read
Speakers: Lakshmi Devi, Mount Sinai School of Medicine; Jonathan Javitch, Columbia U.; Craig Lindsley, Vanderbilt U.; Lee-Yuan Liu-Chen, Temple U. School of Medicine; Geneviève Oligny-Longpré, U. of Montreal; Ken Valenzano, Amicus Therapeutics; Jonathan Violin, Trevena Inc.
Moderator: Andrew Marshall, Nature Biotechnology Speakers: Ralph Marcello, Deloitte Consulting LLP; Alan E. Smith, Genzyme; Robert A. Copeland, EpiZyme, Inc.; Cole Werble, The RPM Report; Peter Vaccari, FDA; Barbara B. Mittleman, NIH
RSS